abstract |
The present invention relates to compounds of formula (I) n n nwherein R 1 , R 2 , R 3 R 3a and R 3b are as provided in the description, and pharmaceutically acceptable salts thereof, for use in the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors such as obesity. |